Larvol Delta - A-FIRST-IN-HUMAN-TO-EVALUATE-THE-SAFETY-AND-IMMUNOGENICITY-OF-SARSCoV2-UQSC2-VACCINE-IN-HEALTHY-ADULTS

UQSC2 - University of Queensland, CEPI

Covovax (NVX-CoV2373) - Novavax, Takeda, Serum Institute of India

http://clinicaltrials.gov/ct2/show/NCT05775887

Mar 6, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next